Article

Giant cell tubulitis and tubular basement membrane immune deposits.

*Departments of Anatomical Pathology, Australia †Nephrology, St Vincent's Hospital, Darlinghurst, Australia ‡Department of Neuropathology, Royal Prince Alfred Hospital, Camperdown, Australia §Discipline of Pathology, University of Sydney, Sydney, NSW, Australia.
Pathology (Impact Factor: 2.66). 06/2011; 43(4):383-6. DOI:10.1097/PAT.0b013e3283468772
Source: PubMed
0 0
 · 
0 Bookmarks
 · 
58 Views
  • [show abstract] [hide abstract]
    ABSTRACT: Renal functional abnormalities and evidence of interstitial nephritis are common in Sjögren's syndrome, and it has been suggested that the interstitial changes may be on an immunologic basis. We report a patient with the sicca complex variety of Sjögren's syndrome who presented with renal functional insufficiency and intense interstitial nephritis. Focal tubular basement membrane (TBM) deposits were observed, and immunofluorescence showed focal TBM deposits of IgG and C3. Glomeruli contained no deposits. Therapy with prednisone and cyclophosphamide was associated with marked clinical improvement and regression of tissue leukocyte infiltration. We propose local or in situ formation of immune complexes, as in the rabbit model of autologous immune-complex interstitial nephritis, and suggest that this mechanism may be operative in some patients with Sjögren's syndrome and tubulointerstitial renal disease. Immunosuppressive therapy may have helped to preserve renal function.
    Clinical Immunology and Immunopathology 12/1977; 8(3):494-503.
  • [show abstract] [hide abstract]
    ABSTRACT: Granulomatous interstitial nephritis is a rare condition whose pathogenesis is poorly understood. Of 203 renal biopsies performed between 1974 to 1994 in which interstitial nephritis was the predominant change, granulomata occurred in 12. The authors reviewed the records of these patients and performed immunopathologic and immunohistochemical studies in their biopsies to characterize the phenotype of infiltrating cells. The authors used markers for T cells, B cells, and macrophages, and determined whether they were activated through assessment of upregulation of HLA-DR molecules. Additionally, the authors attempted to delineate whether or not tubules contributed to giant cell formation through assessment of intermediate filament for keratins and macrophage markers in epithelioid cells. Drug (aspirin, gentamycin, or combination of drugs), infection (Echerichia coli or various organisms), and sarcoidosis accounted for granulomatous inflammation in three patients each, Wegener's granulomatosis and oxalosis resulting from intestinal bypass in one patient each, and in one patient the possible cause could not be determined. Except for biopsies of granulomatous inflammation resulting from infection, in which neutrophils predominated, in all other biopsies, T cells and macrophages made up most of the inflammatory cell infiltrate. HLA-DR was upregulated in mononuclear cells infiltrating the interstitium and was expressed in proximal tubular cells and endothelial cells in all but biopsies of patients with sarcoidosis. In no instance was there evidence that tubules contributed epithelial cells to giant cell formation. These findings are consistent with the notion that granulomatous interstitial nephritis is a cell-mediated form of tissue injury in which T cell-macrophage seem to play a major role.
    Human Pathlogy 01/1996; 26(12):1347-53. · 2.84 Impact Factor
  • [show abstract] [hide abstract]
    ABSTRACT: Predominant tubulointerstitial lupus nephritis is rare. Only eight cases have been described in the literature. We report the case of a 59-year-old man with systemic lupus erythematosus who presented with acute renal failure. On renal biopsy, he was found to have chronic tubulointerstitial nephritis with a mononuclear infiltrate. The immunofluorescence showed immune deposits in the tubular basement membranes, interstitium, and glomerular capsule. The glomeruli were minimally involved. He was initially treated with high-dose corticosteroids and supported with hemodialysis. Renal function improved and dialysis was discontinued after three treatments. The corticosteroid dosage was gradually tapered. Renal function after 72 months of follow-up has remained stable (serum creatinine, approximately 1.9 mg/dL) and except for one relapse, there has been no clinical or serologic evidence of lupus activity. Furthermore, 24-hour urinary protein excretion has remained within the normal range.
    American Journal of Kidney Diseases 03/1996; 27(2):273-8. · 5.29 Impact Factor

Lianne Lee